Correlation Between Logistea A and AlzeCure Pharma

Can any of the company-specific risk be diversified away by investing in both Logistea A and AlzeCure Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Logistea A and AlzeCure Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Logistea A and AlzeCure Pharma, you can compare the effects of market volatilities on Logistea A and AlzeCure Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Logistea A with a short position of AlzeCure Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Logistea A and AlzeCure Pharma.

Diversification Opportunities for Logistea A and AlzeCure Pharma

-0.76

Correlation Coefficient

Logistea A  AlzeCure Pharma

Pay attention - limited upside

The 3 months correlation between Logistea and AlzeCure is -0.76. Overlapping area represents the amount of risk that can be diversified away by holding Logistea A and AlzeCure Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AlzeCure Pharma and Logistea A is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Logistea A are associated (or correlated) with AlzeCure Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AlzeCure Pharma has no effect on the direction of Logistea A i.e., Logistea A and AlzeCure Pharma go up and down completely randomly.

Pair Corralation between Logistea A and AlzeCure Pharma

Assuming the 90 days trading horizon Logistea A is expected to generate 0.25 times more return on investment than AlzeCure Pharma. However, Logistea A is 3.98 times less risky than AlzeCure Pharma. It trades about 0.18 of its potential returns per unit of risk. AlzeCure Pharma is currently generating about -0.02 per unit of risk. If you would invest  1,140  in Logistea A on February 18, 2024 and sell it today you would earn a total of  280.00  from holding Logistea A or generate 24.56% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Logistea A  vs.  AlzeCure Pharma

Logistea A

Risk-Adjusted Performance

14 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Logistea A are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. Despite somewhat uncertain basic indicators, Logistea A sustained solid returns over the last few months and may actually be approaching a breakup point.

AlzeCure Pharma

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days AlzeCure Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest uncertain performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Pair Trading with Logistea A and AlzeCure Pharma

The main advantage of trading using opposite Logistea A and AlzeCure Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Logistea A position performs unexpectedly, AlzeCure Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AlzeCure Pharma will offset losses from the drop in AlzeCure Pharma's long position.

The idea behind Logistea A and AlzeCure Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.